Literature DB >> 11479157

Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.

C Oddoze1, S Morange, H Portugal, Y Berland, B Dussol.   

Abstract

This study evaluated serum cystatin C as a potential new marker of glomerular filtration rate (GFR) in 49 patients who had steady-state diabetes with early renal impairment. We determined the correlation between GFR measured by chromium 51-labeled EDTA and levels of serum cystatin C, serum creatinine, serum beta(2)-microglobulin, endogenous creatinine clearance, and Cockcroft formula. Sensitivity and specificity for the diagnosis of renal failure, defined as a GFR less than either 80 or 60 mL/min/1.73 m(2), were calculated by receiver operating characteristic (ROC) curves for creatinine, cystatin C, and beta(2)-microglobulin. Finally, we compared mean values of these three serum parameters in patients grouped according to GFR using the two definitions of renal failure. Correlation coefficients with GFR were -0.77 for serum creatinine level, -0.65 for serum cystatin C level, -0.71 for serum beta(2)-microglobulin level, +0.56 for endogenous creatinine clearance, and +0.69 for Cockcroft formula (all P < 0.001). With a cutoff value of 60 mL/min/1.73 m(2), areas under the ROC curve were 0.972 for beta(2)-microglobulin, 0.925 for cystatin C, and 0.916 for creatinine levels. With a cutoff value of 80 mL/min/1.73 m(2), these were 0.838 for beta(2)-microglobulin, 0.780 for cystatin C, and 0.905 for creatinine levels (P = not significant between parameters). These results were not altered after the exclusion of patients (n = 8) with a serum creatinine level greater than 1.41 mg/dL. When patients were classified into three groups according to GFR (group 1, >80 mL/min/1.73 m(2); group 2, 60 to 80 mL/min/1.73 m(2); group 3, <60 mL/min/1.73 m(2)), mean values of serum parameters in the three groups were statistically different (P < 0.0001) except between groups 1 and 2 for cystatin C and beta(2)-microglobulin. With patients classified into two groups (GFR > or < 80 mL/min/1.73 m(2)), mean values for each parameter were statistically different (P < 0.001). Sensitivity, specificity, and positive and negative predictive values for serum creatinine and serum cystatin C levels were very close for both definitions of renal failure. Serum cystatin C is not better than serum creatinine or serum beta(2)-microglobulin levels for estimating GFR in patients with steady-state diabetes using ROC curves or other validation tests.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479157     DOI: 10.1053/ajkd.2001.26096

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  19 in total

Review 1.  Commentary: clinical diagnostic use of cystatin C.

Authors:  Davis Massey
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

Review 2.  The applicability of eGFR equations to different populations.

Authors:  Pierre Delanaye; Christophe Mariat
Journal:  Nat Rev Nephrol       Date:  2013-07-16       Impact factor: 28.314

3.  Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker.

Authors:  Ghada Al-Kafaji; Ghazi Al-Mahroos; Haifa Abdulla Al-Muhtaresh; Cristina Skrypnyk; Mohamed Abdalla Sabry; Ahmad R Ramadan
Journal:  Exp Ther Med       Date:  2016-05-26       Impact factor: 2.447

Review 4.  Cystatin C, kidney function and cardiovascular disease.

Authors:  Arend Bökenkamp; Stefan Herget-Rosenthal; Regina Bökenkamp
Journal:  Pediatr Nephrol       Date:  2006-07-13       Impact factor: 3.714

5.  Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.

Authors:  R Shahni; L Gnudi; A King; P Jones; A N Malik
Journal:  Diabetologia       Date:  2011-11-18       Impact factor: 10.122

6.  The costs and benefits of automatic estimated glomerular filtration rate reporting.

Authors:  Julia R den Hartog; Peter P Reese; Borut Cizman; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

7.  Serum cystatin C assay for the detection of early renal impairment in diabetic patients.

Authors:  Li Hai Xia; Xu Guo Bing; Xia Tie An
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

8.  Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.

Authors:  Yun Kyung Jeon; Mi Ra Kim; Jung Eun Huh; Ji Young Mok; Sang Heon Song; Sang Soo Kim; Bo Hyun Kim; Soo Hyoung Lee; Yong Ki Kim; In Joo Kim
Journal:  J Korean Med Sci       Date:  2011-01-24       Impact factor: 2.153

9.  Serum cystatin C reflects the progress of albuminuria.

Authors:  Jeong Seon Yoo; Young Mi Lee; Eun Hae Lee; Ji Woon Kim; Shin Young Lee; Ki-Cheon Jeong; Shin Ae Kang; Jong Suk Park; Joo Young Nam; Chul Woo Ahn; Young Duk Song; Kyung Rae Kim
Journal:  Diabetes Metab J       Date:  2011-12-26       Impact factor: 5.376

10.  Estimated glomerular filtration rate correlates poorly with four-hour creatinine clearance in critically ill patients with acute kidney injury.

Authors:  Christopher J Kirwan; Barbara J Philips; Iain A M Macphee
Journal:  Crit Care Res Pract       Date:  2013-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.